Presentation on theme: "Male Hypogonadism: Facts and Myths. Case#1 A 49 years old man referred for diabetes management. Review of other symptoms is positive for fatigue,"— Presentation transcript:
Male Hypogonadism: Facts and Myths
Case#1 A 49 years old man referred for diabetes management. Review of other symptoms is positive for fatigue, lack of motivation, and decreased libido with preserved erectile function. The exam revealed central obesity, A1C of 8.9%, elevated TG, and low HDL.
Which of the following about low testosterone in diabetics is true? Hypogonadism is rare in diabetics The incidence of hypogonadism in diabetics approaches 30% across all age groups. Hypogonadism occurs only in diabetic older than 65 year old. All men with diabetes will eventually develop hypogonadism.
Based on recent studies, which of the following symptoms would make you suspicious of low level of testosterone? Decreased level of energy Lack of motivation Diminished libido Moodiness and irritability Erectile dysfunction
Case# 2 A 68 years old man is admitted with a hip fracture as a result of falling from standing position. Five ears earlier, he had a forearm fracture due to a minor injury. He admits losing 2 inches of height. Mild kyphosis is detected on exam
The Initial W/U should include all except: CBC Thoracic Spine Xray CMP Vitamin D evaluation Testoterone level Dexa Scan Bone Scan
Which one of the following do not need to be obtained prior to initiating T. ? PSA Hematocrit Prolactin, LH, and FSH Glucose MRI of pituitary
Contraindications of Testosterone Replacement Therapy in Men Known or suspected prostate cancer Male breast cancer Known or suspected sensitivity to ingredients used in testosterone therapy systems Petak SM, et al. AACE Clinical Practice Guidelines. Available at:
Testosterone Therapy and Possible Prostate Changes Increased risk of BPH Increases in PSA levels Increases in prostate volume Stimulation of growth in previously undiagnosed tumors –No data support testosterone therapy as a cause of prostate cancer Hajjar RR, et al. J Clin Endocrinol Metab. 1997:82; Basaria S, et al. Drugs Aging. 1999;15:
Keep your finger on the prostate
Potential Risks of Testosterone Therapy Prostatic hyperplasia and prostate cancer in those already at increased risk Edema in patients with preexisting cardiac, renal, or hepatic disease Gynecomastia Precipitation or worsening of sleep apnea Hepatic adverse effects with oral therapy Petak SM, et al. AACE Clinical Practice Guidelines. Available at:
Case#3 A 32 year old man is receiving narcotic therapy for advanced ankylosing spondylitis. He is complaining of night sweat and depressive mood.
What lab set would confirm the diagnosis of hypogonadism? Total T of less than 200 ng/ml with elevated LH Total T of less than 300 ng/ml with normal LH A recent drop of 300 ng/ml of Total T with normal LH Total T of 350 ng/ml with elevated LH
Which of the following treatment option is the mainstay of testosterone replacement therapy that avoids level swings? Testosterone patch Testosterone pellets Testosterone injections Testosterone gel Buccal testosterone
Endocrinology=Proper Hormone replacement Medicine: Quality of life> Quantity of life
The Endocrine society 2006 suggested measurement of T. for: Type 2 DM Osteoporosis or low trauma fracture especially younger patients. Moderate to severe COPD ESRD and hemodialysis HIV-associated weight loss Meds affect testosterone production such as glucocorticoids, ketoconazole, and opioids Sellar region disease.